Effects of retinoic acid on cell differentiation and reversion toward normal in human endometrial adenocarcinoma (RL95-2) cells

Anticancer Research

Volumn 16, Issue 1, 1996, Pages 17-24

  Carter, Charleata A ^a   Pogribny, Marta ^b   Davidson, April ^b   Jackson, C D ^b   Mcgarrity, Lynda J ^b   Morris, Suzanne M ^b  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

Author keywords

Endometrium; F actin; Retinoic acid; RL95 2 cells

Indexed keywords

F ACTIN; ISOTRETINOIN; RETINOIC ACID;

ACTIN FILAMENT; ARTICLE; CELL CULTURE; CELL CYCLE S PHASE; CELL DIFFERENTIATION; CELL GROWTH; CELL SIZE; CELL TRANSFORMATION; CONTROLLED STUDY; CYTOSKELETON; DRUG EFFECT; DRUG MECHANISM; ENDOMETRIUM CARCINOMA; HUMAN; HUMAN CELL; METASTASIS; PHENOTYPE; PRIORITY JOURNAL;

ACTINS; ADENOCARCINOMA; CELL ADHESION; CELL DIFFERENTIATION; CELL DIVISION; CELL SIZE; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; ISOTRETINOIN; KINETICS; PHENOTYPE; TRETINOIN;

EID: 0029922956     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Boring CC, Squires TS, Tong T and Montgomery S: Cancer statistics. CA Cancer J Clin 44: 7-26, 1994.
2. Magriples A, Naftolin F, Schwarz PE and Carcangiu ML: High grade endometrial carcinoma in tamoxifen treated breast cancer patients. J Clin Oncol 11: 485-490, 1993.
3. Nayfield SG, Karp JE, Ford LG, Dorr FA and Kramer BS: Potential role of tamoxifen in prevention of breast cancer. J Natl Cancer Inst 83: 1450-1459, 1991.
4. Lahti E, Blanco G, Kauppila A, Apaja-Sarkkinen M, Taskinen PJ and Laatikainen T Endometrial changes in postmenopausal breast cancer patients receiving tamoxifen. Obstet and Gynecol 81: 660-664, 1993.
5. Rubin M, Fenig E, Rosenauer A, Menendez-Botet C, Achkar C, Bentel JM, Yahalom J, Mendelsohn J and Miller WH: 9-cis retinoic acid inhibits growth of breast cancer cells and down-regulates estrogen receptor RNA and protein Cancer Res 54. 6549-6556, 1994.
6. Budd GT, Gupta M, Ganapathi R, Adamson P, Karnik P, Sandatrom K, McLain D and Bukowski RM: Phase I trial of trans-retinoic acid and tamoxifen in advanced breast cancer. Proc of the Amer Assoc for Cancer Res 35: 229A, 1994.
7. Kudelka AP, Freedman RS, Edwards CL, Lippman SM, Tornos CS, Krakoff IH and Kavanagh JJ: Metastatic adenocarcinoma of the endometrium treated with 13-cis-retinoic acid plus interferon-α. Anti-Cancer Drugs 4: 335-337, 1993.
8. Hong WK and Itri LM: Retinoids and human cancer. In: The Retinoids: Biology, Chemistry, and Medicine (Sporn MB, Roberts AB and Goodman DS, eds.). New York, Raven Press, 1994, pp 597-630.
9. Underwood BA: Vitamin A in animal and human nutrition. In: The Retinoids Vol 1. (Sporn MB, Roberts AB and Goodman DS eds.). London, Academic Press, 1984, pp. 283-392
10. Bollag W, Peck R and Frey JR: Inhibition of proliferation by retinoids, cytokines and their combination in four human transformed epithelial cell lines. Cancer Letters 62: 167-172, 1992.
11. Yang XY: Retinoic acid influences cell proliferation in human tumor cell lines by modulation of the expression of the epidermal growth factor receptor and the differentiation related gene pRA538. Proc of the Amer Assoc for Cancer Res 34: 3017A, 1993.
12. Sherman MI, Matthaei KI and Schindler J: Studies on the mechansim of induction of embryonal carcinoma cell differentiation by retinoic acid. Ann NY Acad Sci 359: 192-199, 1981.
13. Sidell N: Retinoic acid-induced growth inhibition and morphologic differentiation of human neuroblastoma cells in vitro. J Natl Cancer Inst 68: 589-593, 1982.
14. Strickland S and Madhavi V: The induction of differentiation in teratocarcinoma stem cells by retinoic acid. Cell 15: 393-403, 1978.
15. Lehtonen E, Lehto V-P, Badley R A, and Virtanen I: Formation of vinculin plaques precedes other cytoskeletal changes during retinoic acid-induced teratocarcinoma cell differentiation. Exp Cell Res 144: 191-197, 1983.
16. Helige C, Smolle J, Zellnig G, Hartmann E, Fink-Puches R, Kerl H, and Tritthart HA: Inhibition of K1735-M2 melanoma cell invasion in vitro by retinoic acid. Clin Exp Metastasis, 11: 409-418, 1993.
17. Hendrix MJC, Wood WR, Seftor EA, Lotan D, Nakajima M, Misiorowski RL, Seftor REB, Stetler-Stevenson WG, Bevacqua SJ, Liotta LA, Sobel ME, Raz, A and Lotan, R: Retinoic acid inhibition of human melanoma cell invasion through a reconstituted basement membrane and its relation to decreases in the expression of proteolytic enzymes and motility factor receptor. Cancer Res 50: 4121-4130, 1990.
18. Carter CA, Rinehart CA, Bagnell CR and Kaufman DG: Fluorescent laser scanning microscopy of F-actin disruption in human endometrial stromal cells expressing the SV40 large T antigen and the EJ ras oncogene. Pathobiology 59. 36-45, 1991.
19. Dolbeare F, Gratzner HG, Pallavicini MG and Gray JW: Flow cytometric measurement of total DNA content and incorporated bromodeoxyuridine Proc Natl Acad Sci USA 80: 5573-5577, 1983.
20. Ben Ze'ev A: The cytoskeleton in cancer cells. Biochim Biophys Acta 780: 197-212, 1985.
21. Pienta KJ, Partin AW and Coffey DS: Cancer as a disease of DNA organization and dynamic cell structure. Cancer Res 49: 2525-2532, 1989.
22. Carter CA, Doherty MM, Rusnak DW, Nettesheim P and Ferriola PC: Alterations in the localization of F-actin, fibronectin, and thrombospondin occur prior to neoplastic transformation in rat tracheal epithelial cells. Expt Cell Res 212: 141-150, 1994.
23. Bissel MJ, Hall H G and Parry GJ. How does the extracellular matrix direct gene expression? J Theor Biol 99: 31-68, 1982.
24. Byers HR, White GE and Fujiwara K: Organization and function of stress fibers in cells in vitro and in situ: In: Cell and Muscle Motility (Shay J W, ed.), New York, Plenum Press, 1983, pp 83-137.
25. Kolega J: Effects of mechanical tension on protrusive activity and microfilament and intermediate filament organization in an epidermal epithelium moving in culture. J Cell Biol 102: 1400-1411, 1986.
26. Lewis L, Verna JM, Levinstone D, Sher S, Marek L and Bell E: The relationship of fibroblast translocation. J Cell Sci 53: 21-36, 1982.
27. Vasiliev JM: Spreading of non-transformed and transformed cells. Biochemica et Biophysica Acta 780: 21-65, 1985.
28. Harris AK, Wild P and Stopak D: Silicone rubber substrata: A new wrinkle in the study of cell locomotion. Science 208: 177-179, 1980.
29. Harris AK: Cell traction and its relation to morphogenesis and malignancy. Amer Zool 26: 559-560, 1986
30. Way DL, Grosso DS, Davis JR, Surwit EA and Christian CD: Characterization of a new human endometrial carcinoma (RL95-2) established in tissue culture. In Vitro 19: 147-158, 1983.
31. Hossain MZ and Bertram JS: Retinoids suppress proliferation, induce cell spreading, and up-regulate connexin 43 expression only in postconfluent 10T1/2 cells: Implications for the role of gap junctional communication. Cell Growth and Diff 5: 1253-1261, 1994.
32. Mordan LJ and Bertram JS: Retinoid effects on cell-cell interactions and growth characteristics of normal and carcinogen-treated C3H/10T1/2 cells. Cancer Res 43: 567-571, 1983.
33. Atencia R, García-Sanz M, Unda F and Aréchaga J: Apoptosis during retinoic acid-induced differentiation of F9 embryonal carcinoma cells. Exp Cell Res 214: 663-667, 1994.
34. Benner SE, Pritsche HA, Lee JS, Lippman SM and Hong WK: Serum retinol levels following 13-cis retinoic acid administration in a chemoprevention trial. Proc of the Amer Assoc for Cancer Res 36: 3504A, 1995.
35. Pokras R and Hufnagel V: Hysterectomies in the United States. In: National Health Survey, DHHS Publication PHS 88-1753, Series 13, #92, pp. 1-26, 1987.
36. Chambers SK, Kapp DS, Peschel RE, Lawrence R, Merino M, Kohorn EI and Schwartz PE: Prognostic factors and sites of failure in Figo Stage I, Grade 3 endometrial carcinoma. Gynecol Oncol 27: 180-188, 1987.
37. Darwiche N, Celli G, Sly L, Lancillotti F and DeLuca LM: Retinoid status controls the appearance of reserve cells and keratin expression in mouse cervical epithelium. Cancer Res 53: 2287-2299, 1993.
38. Palan PR, Mikhail MS, Basu J and SL Romney: Plasma levels of antioxidant α-carotene and α-tocopherol in uterine cervix dysplasias and cancer. Nutr Cancer 15: 13-20, 1991.
39. Ahn WS, Lippman SM, Kavanagh JJ, Silva EG, Hong WK, Krakoff IH and WN Hittelman: Biological basis of response of cervical squamous cell carcinoma to alpha interferon and 13-cis retinoic acid. Proc Amer Assoc Cancer Res 34: 446A, 1993.